Diamond Institute for Infertility and Menopause

The Diamond Institute for Infertility and Menopause, headquartered in the United States, functions as a specialized healthcare provider dedicated to the diagnosis and treatment of infertility and menopause-related conditions. Its core services encompass clinical care for reproductive health and hormonal disorders, which includes managing diagnostic procedures such as laboratory testing and sonographic imaging, as indicated by the types of patient documents referenced in a documented security incident. The institute serves a domestic patient population within the U.S. healthcare market, maintaining electronic health records that contain highly sensitive personal and medical information, including names, addresses, Social Security numbers, lab results, and sonograms. This operational focus on a specific segment of women's health positions it within a niche sector of medical service providers.

The institute's scale is substantiated by its patient volume, as a known security breach in February 2017 impacted over 14,000 individuals, indicating a substantial repository of active patient records. That incident involved a third-party server hosting the institute's electronic health records, where an unauthorized actor accessed encrypted data but potentially compromised unencrypted support documents containing the sensitive information listed above. Upon discovery, the Diamond Institute launched an internal investigation, engaged law enforcement, and reported the breach to federal regulators, adhering to mandatory notification protocols. Affected patients were subsequently offered credit monitoring services as a remedial measure. The event highlights the institute's handling of protected health information and its procedural response to data security failures within the regulated healthcare environment. No explicit details regarding ownership structure or parent-subsidiary relationships are provided in the available information.